AMN Healthcare Services schedules November 5 results for AMN stock

Published on 10/17/2026 at 20:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AMN's trailing P/E was 15.11 on October 16, 2026. AMN stock costs USD 40.49 on October 16, 2026 at close, up 1.23 percent on the NYSE.

Results date and valuation

AMN Healthcare Services scheduled its third-quarter results for November 5, 2026.
The trailing P/E stood at 15.11 on October 16, 2026.
AMN stock costs USD 40.49 on October 16, 2026 at 4:00 p.m. EDT, up 1.23 percent on the NYSE.
Market capitalization stood at USD 1.6 billion on October 16, 2026.

AMN, US0017441017, Illustration mit AI erstellt.

AMN Healthcare Services (ISIN US0017441017) scheduled its third-quarter 2026 results for November 5, 2026, with the release expected after the market close and the conference call at 5:00 p.m. ET, according to PR Newswire. AMN stock last traded at USD 40.49 on the NYSE on October 16, 2026 at 4:00 p.m. EDT, up 1.23 percent from the prior close.

Results date sets the next checkpoint

The November 5 release will cover the third quarter and include the company's fourth-quarter 2026 outlook. The timing gives investors a defined checkpoint after a sharp year-to-date advance of 156.92 percent through October 16, 2026.

AMN stock stays near its yearly high

AMN closed October 16, 2026 at USD 40.49, inside its 52-week range of USD 14.97 to USD 41.51. The closing price was USD 1.02 below the high, equal to 2.46 percent below that level. The session range was USD 39.90 to USD 41.51, while volume reached 1,545,760 shares against an average of 682,790.

The move has materially changed the stock's placement within its annual range. Its market capitalization stood at USD 1.6 billion on October 16, 2026, and the trailing price-to-earnings ratio was 15.11. The company reported 2,664 full-time employees in its latest profile, while its business spans nurse and allied staffing, physician recruitment and workforce technology.

Valuation and the November calendar

AMN's next scheduled corporate date is November 5, 2026. The company said the earnings release should arrive at approximately 4:15 p.m. ET, followed by the call at 5:00 p.m. ET, giving the date a clear after-hours reporting timetable.

BMO Capital had raised its AMN price target from USD 40.00 to USD 43.00 on October 9, 2026, while keeping an Outperform rating, as reported by Markets Insider. That target is a separate valuation reference from the scheduled results date.

Investor calendar stays central

The upcoming report will test whether the company's operating trends can support the valuation implied by the recent share price. For investors, the key measurable markers are the November 5 results, the USD 40.49 closing price and the stock's 2.46 percent distance from its 52-week high.

Price and market position

AMN Healthcare Services last traded at USD 40.49 on the NYSE on October 16, 2026 at 4:00 p.m. EDT, up 1.23 percent from the prior close. The shares remained below the USD 41.51 52-week high, while the USD 14.97 low shows the size of the year's trading range.